{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:20:08Z","timestamp":1787721608145,"version":"build-2784847793"},"reference-count":71,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The use of animal models to study mental illnesses, such as depression, requires proper standardization and extensive expertise. Achieving good construct, face, and predictive validity in depression models is quite challenging. Currently, only a few environmental models, mostly based on chronic stress, and a limited number of genetic models fulfill these criteria. In the quest for new antidepressants, initial screening tests are employed as a preliminary step in research. While these tests do not always meet the requirements of a disease model, they are useful for the early identification of substances that may have antidepressant potential, paving the way for further studies based on established models. This approach to discovering antidepressants was originally designed for traditional medications, which typically act by modulating serotonergic, noradrenergic, and dopaminergic systems, and require multi-week administration to produce a therapeutic effect. In contrast, the new antidepressant ketamine offers rapid therapeutic effects following a single dose and exhibits distinctive behavioral outcomes in both screening tests and animal depression models. These effects have inspired a new model for the search for rapid-acting ketamine-like antidepressants. This review presents the behavioral effects of ketamine and discusses the methodologies used in the search for novel rapid-acting antidepressant drugs (RAADs).<\/jats:p>","DOI":"10.3390\/biom16091230","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:20:28Z","timestamp":1787592028000},"page":"1230","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of Potential Therapeutic Effects of New Rapid-Acting Antidepressant Drugs (RAADs) Using Stress-Based Models of Depression"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-6844","authenticated-orcid":false,"given":"Agnieszka","family":"Pa\u0142ucha-Poniewiera","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.153.2.151","article-title":"Initiation and adaptation: A paradigm for understanding psychotropic drug action","volume":"153","author":"Hyman","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an NMDA antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"l7069","DOI":"10.1136\/bmj.l7069","article-title":"Esketamine is approved in Europe for treating resistant major depressive disorder","volume":"367","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2019.07.076","article-title":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","volume":"258","author":"Muttoni","year":"2019","journal-title":"J. Affect. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0149-7634(05)80194-0","article-title":"Chronic mild stress-induced anhedonia: A realistic animal model of depression","volume":"16","author":"Willner","year":"1992","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5.65.1","DOI":"10.1002\/0471141755.ph0565s61","article-title":"Models of depression: Unpredictable chronic mild stress in mice","volume":"61","author":"Nollet","year":"2013","journal-title":"Curr. Protoc. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ilar\/ilu002","article-title":"Social defeat as an animal model for depression","volume":"55","author":"Hollis","year":"2014","journal-title":"ILAR J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00441-013-1654-2","article-title":"Learned helplessness: Unique features and translational value of a cognitive depression model","volume":"354","author":"Vollmayr","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3000605221075816","DOI":"10.1177\/03000605221075816","article-title":"Validity of chronic restraint stress for modeling anhedonic-like behavior in rodents: A systematic review and meta-analysis","volume":"50","author":"Mao","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nishi, M., Horii-Hayashi, N., and Sasagawa, T. (2014). Effects of early life adverse experiences on the brain: Implications from maternal separation models in rodents. Front. Neurosci., 8.","DOI":"10.3389\/fnins.2014.00166"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","author":"Willner","year":"2016","journal-title":"Neurobiol. Stress"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jad.2020.10.040","article-title":"Antidepressant treatment is associated with epigenetic alterations of Homer1 promoter in a mouse model of chronic depression","volume":"279","author":"Sun","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression-25 years and still producing","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/FBP.0000000000000431","article-title":"Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression","volume":"30","author":"Willner","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.neuroscience.2009.01.072","article-title":"Neurochemical and behavioral alterations in an inflammatory model of depression: Sex differences exposed","volume":"159","author":"Pitychoutis","year":"2009","journal-title":"Neuroscience"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2020.03.022","article-title":"Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression","volume":"268","author":"Tomaz","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jnc.13596","article-title":"Elevation of cortical serotonin transporter activity upon peripheral immune challenge is regulated independently of p38 mitogen-activated protein kinase activation and transporter phosphorylation","volume":"137","author":"Schwamborn","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1300532","article-title":"Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration","volume":"29","author":"Strekalova","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cathomas, F., Hartmann, M.N., Seifritz, E., Pryce, C.R., and Kaiser, S. (2015). The translational study of apathy-an ecological approach. Front. Behav. Neurosci., 9.","DOI":"10.3389\/fnbeh.2015.00241"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2004.04.020","article-title":"Susceptibility to subchronic unpredictable stress is related to individual reactivity to threat stimuli in mice","volume":"155","author":"Ducottet","year":"2004","journal-title":"Behav. Brain Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: A new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioural despair\u201d in rats and mice: Strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: A new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.psyneuen.2015.08.028","article-title":"Immobility in the forced swim test is adaptive and does not reflect depression","volume":"62","author":"Molendijk","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","article-title":"A standardization of the novelty-suppressed feeding test protocol in rats","volume":"658","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-021-05982-w","article-title":"Chronic mild stress paradigm as a rat model of depression: Facts, artifacts, and future perspectives","volume":"239","author":"Strekalova","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biopsych.2013.12.014","article-title":"Effects of striatal \u0394FosB overexpression and ketamine on social defeat stress-induced anhedonia in mice","volume":"76","author":"Donahue","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1038\/tp.2016.21","article-title":"Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model","volume":"6","author":"Sun","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainresbull.2017.12.005","article-title":"Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events","volume":"137","author":"Maciel","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ma, X.C., Dang, Y.H., Jia, M., Ma, R., Wang, F., Wu, J., Gao, C.G., and Hashimoto, K. (2013). Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056053"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"110239","DOI":"10.1016\/j.pnpbp.2020.110239","article-title":"The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL\/6J mice","volume":"109","author":"Podkowa","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1038\/srep13573","article-title":"Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice","volume":"5","author":"Tang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113633","DOI":"10.1016\/j.bbr.2021.113633","article-title":"The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL\/6J mice","volume":"418","year":"2022","journal-title":"Behav. Brain Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","article-title":"Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \u201cdepressed\u201d mice exposed to chronic mild stress","volume":"290","author":"Franceschelli","year":"2015","journal-title":"Neuroscience"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pnpbp.2009.01.004","article-title":"Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats","volume":"33","author":"Garcia","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jnc.14544","article-title":"Subanesthetic ketamine reverses neuronal and astroglial metabolic activity deficits in a social defeat model of depression","volume":"146","author":"Mishra","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41386-022-01314-4","article-title":"Nicotinic receptors promote susceptibility to social stress in female mice linked with neuroadaptations within VTA dopamine neurons","volume":"47","author":"Ortiz","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"173316","DOI":"10.1016\/j.pbb.2021.173316","article-title":"Antidepressant-like actions of the mGlu2\/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram","volume":"212","author":"Dong","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41380-025-03209-4","article-title":"Rapid and long-lasting antidepressant-like effects of the pituitary adenylate cyclase-activating polypeptide receptor antagonist PA-915 in chronic stress mouse models","volume":"31","author":"Shintani","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45393","DOI":"10.1038\/s41598-025-29642-7","article-title":"A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model","volume":"15","author":"Kwiatkowska","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10253890.2022.2045269","article-title":"A single dose of ketamine cannot prevent protracted stress-induced anhedonia and neuroinflammation in rats","volume":"25","author":"Guerrin","year":"2022","journal-title":"Stress"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","article-title":"Restoring mood balance in depression: Ketamine reverses deficit in dopamine-dependent synaptic plasticity","volume":"76","author":"Belujon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: Comparison with (R)-ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2011.47","article-title":"Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice","volume":"16","author":"Beurel","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.115.225664","article-title":"The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/GlycineB-site inhibition","volume":"355","author":"Zanos","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"110947","DOI":"10.1016\/j.neuropharm.2026.110947","article-title":"N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: A comparative study with S-ketamine","volume":"292","author":"Moura","year":"2026","journal-title":"Neuropharmacology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00213-022-06201-w","article-title":"Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway","volume":"239","author":"Lyu","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pochwat, B., Misztak, P., Masternak, J., B\u0105czy\u0144ska, E., Bijata, K., Roszkowska, M., Bijata, M., W\u0142odarczyk, J., Szafarz, M., and Wyska, E. (2022). Combined hyperforin and lanicemine treatment instead of ketamine or imipramine restores behavioral deficits induced by chronic restraint stress and dietary zinc restriction in mice. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.933364"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1111\/bph.17324","article-title":"Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant-like effects of ketamine","volume":"181","author":"Yin","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e70891","DOI":"10.1096\/fj.202501763R","article-title":"Ketamine reverses chronic stress-induced behavioral changes via the expression of Ca(2+)-permeable AMPA receptors in mice","volume":"39","author":"Flowers","year":"2025","journal-title":"FASEB J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"113598","DOI":"10.1016\/j.biopha.2022.113598","article-title":"Effects of fast-acting antidepressant drugs on a postpartum depression mice model","volume":"154","author":"Valverde","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00213-016-4327-5","article-title":"Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression","volume":"233","author":"Liebenberg","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/s41380-020-0685-9","article-title":"Prefrontal cortex circuits in depression and anxiety: Contribution of discrete neuronal populations and target regions","volume":"25","author":"Hare","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neubiorev.2021.05.003","article-title":"The anterior cingulate cortex as a key locus of ketamine\u2019s antidepressant action","volume":"127","author":"Alexander","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-025-02288-9","article-title":"The hippocampus as a central hub in ketamine\u2019s antidepressant action: From molecules to circuit rewiring","volume":"51","author":"Park","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tins.2018.12.002","article-title":"Lateral habenular burst firing as a target of the rapid antidepressant effects of ketamine","volume":"42","author":"Cui","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor signaling in depression and antidepressant action","volume":"90","author":"Monteggia","year":"2021","journal-title":"Biol. Psychiatry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1230\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:27:35Z","timestamp":1787718455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biom16091230"],"URL":"https:\/\/doi.org\/10.3390\/biom16091230","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}